Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.trsl.2020.05.007 http://scihub22266oqcxt.onion/10.1016/j.trsl.2020.05.007 32504825!7267803!32504825     free     free     free       Transl+Res 2020 ; 224 (ä): 71-77 Nephropedia Template TP {{tp|p=32504825|t=2020. Innovative highlights of clinical drug trial design |pdf=|usr=}}{{32504825}} gab.com Text Innovative highlights of clinical drug trial design JO: Transl Res http://www.kidney.de/pget.php?&tw=1&pmid=32504825 #FOAvip Clinical trials serve as the gold standard to evaluate the efficacy and safety of tested drugs prior to marketing authorization. Nevertheless, there have been a few challenging issues well noted in traditional clinical trials such as tedious processing duration and escalating high costs among others. To improve the efficiency of clinical studies, a spectrum of expedited clinical trial modes has been designed, and selectively implemented in contemporary drug developing landscape. Herein this article presents an update on the innovated human trial designs that are corroborated through coming up with approval of notable therapeutic compounds for clinical utilization including delivery of several blockbuster products. It is intended to inspire clinical investigators and pharmaceutical development not only timely communicating with the regulatory agencies, but also insightful translating from cutting-edge scientific discoveries. Twit Text FOAVip Innovative highlights of clinical drug trial design ????Transl Res http://www.kidney.de/pget.php?&tw=1&pmid=32504825 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32504825 #FOAvip English Wikipedia <ref>{{Cite pmid|32504825}}</ref> Innovative highlights of clinical drug trial design #MMPMID32504825 Chen D; Qi EY Transl Res 2020[Oct]; 224 (ä): 71-77 PMID32504825show ga Clinical trials serve as the gold standard to evaluate the efficacy and safety of tested drugs prior to marketing authorization. Nevertheless, there have been a few challenging issues well noted in traditional clinical trials such as tedious processing duration and escalating high costs among others. To improve the efficiency of clinical studies, a spectrum of expedited clinical trial modes has been designed, and selectively implemented in contemporary drug developing landscape. Herein this article presents an update on the innovated human trial designs that are corroborated through coming up with approval of notable therapeutic compounds for clinical utilization including delivery of several blockbuster products. It is intended to inspire clinical investigators and pharmaceutical development not only timely communicating with the regulatory agencies, but also insightful translating from cutting-edge scientific discoveries. |*Clinical Trials as Topic[MESH] |*Inventions[MESH] |Drug Repositioning[MESH] |Humans[MESH] |Orphan Drug Production[MESH]Innovative highlights of clinical drug trial design (epmc).pdf DeepDyve Pubget Overpricing